The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

EU approval for Alcon’s eye drug, says Novartis

Novartis has said that its eye care division Alcon has received approval for its VMT drug, Jetrea, in Europe. The European Commission has approved Alcon’s Jetrea intravitreal injection in the EU fo...

Alcon’s Jetrea eyes up new markets after EU nod

Novartis’ Alcon division has received EU approval for novel eye drug Jetrea. Here are the details: The News in a Nutshell The EMA has approved Alcon (Novartis)’s novel product Jetrea (oc...

Alcon acquires ophthalmic division of SMI

Addition of SensoMotoric Instruments technology adds capabilities in ocular surgery guidance technology to Alcon's existing global cataract portfolio.

Novartis' Alcon launches Jetrea in Germany

Novartis' Alcon division has launched novel vitreomacular traction drug Jetrea (ocriplasmin) in Germany, its second European market. The drug has launched in Germany at an ex-factory list price of...

BRIEF-Novartis says Alcon subject of U.S. probe related to exports to Iran, others

Jan 23 (Reuters) - Novartis AG : * Says Alcon Laboratories was notified in 2012 of Northern District of Texas probe - SEC filing * Says probe related to exporting products to Iran - SEC filing * Sa...

ThromboGenics-Alcon's Jetrea wins EU nod for vitreomacular traction

ThromboGenics and Novartis unit Alcon obtained approval from the European Commission to market Jetrea, or ocriplasmin, as a t -More- 

Novartis: EU Approves Alcon's Eye Drug Jetrea

BASEL (dpa-AFX) - Novartis (NVS) announced that its Alcon division has received the European Commission approval for Jetrea intravitreal injection or ocriplasmin, eye drug to treat vitreomacular t...

Novartis says Alcon's eye drug Jetrea gets EU approval

ZURICH (Reuters) - Novartis said its Alcon unit got a green light from the European Commission for Jetrea, a drug that treats an eye condition that can lead to blindness.

Deal watch: Alcon invests in first non-surgical therapy for common eye disorder.

Synthesis from d-Altrose of (5R,6R,7R,8S)-5,7-Dihydroxy-8-hydroxymethylconidine and 2,4-Dideoxy-2,4-imino-d-glucitol, Azetidine Analogues of Swainsonine and 1,4-Dideoxy-1,4-imino-d-mannitol.

Ring closure of a 3,5-di-O-triflate derived from d-altrose with benzylamine allowed the formation of both monocyclic and bicyclic azetidine analogues of swainsonine.

Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.

Expression and implication of gangliosides in human osteosarcomas have not been systematically analyzed. In this study, we demonstrated that gangliosides, GD3 and GD2 are highly expressed in the major...

Testing the adjustable threshold model for intruder recognition on Myrmica ants in the context of a social parasite.

Social insect colonies are like fortresses, well protected and rich in shared stored resources. This makes them ideal targets for exploitation by predators, parasites and competitors. Colonies of Myrm...

Residual Astigmatism Following Toric Intraocular Lens Implantation Related to Pupil Size.

PURPOSE:To present two patients with residual astigmatism following toric intraocular lens (IOL) implantation. METHODS:Case reports. RESULTS:A 58-year-old woman underwent toric IOL implantation (spher...